ABDUL SALAM AMEERALI

    DIN: 08091822

    For latest information about the director, visit MCA.

    ABDUL SALAM AMEERALI is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 08091822. ABDUL SALAM AMEERALI is/has been associated with 18 companies.

    This is just one director. Ask about the whole track record.

    Ask Prime Research

    Companies Associated With

    Company Designation Date of Appointment
    WARSEPS HEALTHCARE LLP Designated Partner 22-May-2020
    ASTER CLINICAL LAB LLP Designated Partner 03-Sep-2021
    AMBADY INFRASTRUCTURE PRIVATE LIMITED Director 02-Sep-2021
    HINDUSTAN PHARMA DISTRIBUTORS PRIVATE LIMITED Director 20-Oct-2021
    EMED HUMAN RESOURCES INDIA PRIVATE LIMITED Director 14-Aug-2018
    DM MED CITY HOSPITALS (INDIA) PRIVATE LIMITED Director 10-Sep-2021
    ASTER DM HEALTHCARE (TRIVANDRUM) PRIVATE LIMITED Director 10-Sep-2021
    SRI SAINATHA MULTISPECIALITY HOSPITALS PRIVATE LIMITED Director 08-Nov-2021
    MINDRIOT RESEARCH AND INNOVATION FOUNDATION Director 10-Sep-2021
    MINDRIOT RESEARCH AND DEVELOPMENT PRIVATE LIMITED Director 10-Sep-2021

    Past Companies Associated With

    Company Designation Date of Appointment Date of Cessation
    AMBADY INFRASTRUCTURE PRIVATE LIMITED Additional Director 02-Sep-2021 25-Aug-2022
    HINDUSTAN PHARMA DISTRIBUTORS PRIVATE LIMITED Additional Director 20-Oct-2021 31-Dec-2022
    EMED HUMAN RESOURCES INDIA PRIVATE LIMITED Additional Director 21-May-2018 14-Aug-2018
    DM MED CITY HOSPITALS (INDIA) PRIVATE LIMITED Additional Director 10-Sep-2021 30-Sep-2022
    ASTER DM HEALTHCARE (TRIVANDRUM) PRIVATE LIMITED Additional Director 10-Sep-2021 25-Aug-2022
    SRI SAINATHA MULTISPECIALITY HOSPITALS PRIVATE LIMITED Additional Director 08-Nov-2021 29-Sep-2022
    MINDRIOT RESEARCH AND INNOVATION FOUNDATION Additional Director 10-Sep-2021 31-Oct-2022
    MINDRIOT RESEARCH AND DEVELOPMENT PRIVATE LIMITED Additional Director 10-Sep-2021 31-Oct-2022

    “Assess financial performance of all companies under a director.”

    Ask Prime Research Explore for Sales